Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Gain Therapeutics (GANX) Assets Average (2021 - 2025)

Gain Therapeutics (GANX) has 5 years of Assets Average data on record, last reported at $10.4 million in Q3 2025.

  • For Q3 2025, Assets Average fell 38.01% year-over-year to $10.4 million; the TTM value through Sep 2025 reached $10.4 million, down 38.01%, while the annual FY2024 figure was $15.4 million, 28.04% down from the prior year.
  • Assets Average reached $10.4 million in Q3 2025 per GANX's latest filing, down from $10.7 million in the prior quarter.
  • Across five years, Assets Average topped out at $46.7 million in Q2 2021 and bottomed at $10.4 million in Q3 2025.
  • Average Assets Average over 5 years is $24.3 million, with a median of $19.8 million recorded in 2023.
  • Peak YoY movement for Assets Average: skyrocketed 32.85% in 2022, then crashed 46.26% in 2023.
  • A 5-year view of Assets Average shows it stood at $40.8 million in 2021, then tumbled by 35.71% to $26.2 million in 2022, then plummeted by 37.61% to $16.4 million in 2023, then fell by 19.01% to $13.2 million in 2024, then fell by 21.46% to $10.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Assets Average were $10.4 million in Q3 2025, $10.7 million in Q2 2025, and $11.9 million in Q1 2025.